CD33 and myelodysplastic syndrome: One approach to deplete MDSCs is the use of the 16 × 15 × 33 TriKEs, which, in addition to killing CD33+ malignant cells, are also effective in killing CD33+ MDSCs, leading to restoration of NK cell function in MDS (202, 203).